Lixoft Overview
Latest Deal Amount
$16.5M
Lixoft General Information
Description
Developer of a modeling and simulation platform designed to reduce the cost and increase the success rate of new drug development. The company's platform deals in model-based drug development and advances to the modeling and simulation community in user-friendly tools designed to break the preclinical/clinical/vigilance divide for modeling and simulation, enabling drug developers to share information and synthesize them in studies.
Want to dig into this profile?
We’ll help you find what you need
Learn more
Lixoft Valuation & Funding
| Deal Type |
Date |
Amount |
Raised to Date |
Post-Val |
Status |
Stage |
| 2. Merger/Acquisition |
01-Apr-2020 |
$16.5M |
|
000.00 |
Completed |
Generating Revenue |
| 1. Accelerator/Incubator |
01-Jan-2010 |
|
|
|
Completed |
Startup |
Lixoft Executive Team (2)
| Name |
Title |
Board Seat |
Contact Info |
| Jonathan Chauvin |
Chief Executive Officer |
|
|
| Jérôme Kalifa Ph.D |
Co-Founder & Chairman |
|
|
Lixoft Board Members (1)
| Name |
Representing |
Role |
Since |
| Jérôme Kalifa Ph.D |
Lixoft |
Co-Founder & Chairman |
000 0000
|